Develops innovative catheter-based technologies for the treatment of peripheral artery disease.
Avinger, Inc., a well-established medical device company, operates in the commercial stage, specializing in the design, manufacturing, and global distribution of innovative image-guided systems and catheters. These advanced technologies are essential for physicians treating patients with peripheral arterial disease (PAD) both in the United States and internationally. Central to Avinger's offerings is the lumivascular platform, which integrates optical coherence tomography (OCT) visualization with interventional catheters. This integration enables real-time intravascular imaging during PAD procedures, enhancing precision and efficacy.
The company's lumivascular product portfolio includes the Lightbox imaging consoles and the Ocelot family of catheters. These devices are engineered to navigate through arterial blockages, such as chronic total occlusions (CTOs), providing physicians with the capability to treat complex vascular conditions with greater accuracy. Avinger's Pantheris system further exemplifies its innovation, offering an image-guided atherectomy device that allows precise removal of arterial plaque, thereby restoring blood flow in PAD patients.
Founded in 2007 and headquartered in Redwood City, California, Avinger, Inc. continues to lead the field in medical device technology for PAD treatment. The company's dedication to advancing vascular care is evidenced by its development of the IMAGE-BTK system for below-the-knee PAD lesions. Avinger markets its products directly to interventional cardiologists, vascular surgeons, and interventional radiologists, positioning itself as a trusted partner in the medical community committed to improving patient outcomes through cutting-edge solutions.